ABSTRACT
Vaccines may be scientific wonders, but their value ultimately rests on how well we can get shots into people’s arms. This is an obvious but still overlooked truth that the COVID-19 pandemic has accentuated. Studies have found that a 60 percent efficacious, $35-per-dose COVID-19 vaccine is highly cost-effective ($8,200 per quality-adjusted life-year [QALY]) for the US adult population. Still, a vaccine’s cost-effectiveness depends on how well it is distributed and received.